1627856-64-7,MFCD30747847
Catalog No.:AA01EO24

1627856-64-7 | GSK3179106

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$27.00   $19.00
- +
5mg
98%
in stock  
$66.00   $47.00
- +
10mg
98%
in stock  
$99.00   $69.00
- +
50mg
98%
in stock  
$281.00   $197.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01EO24
Chemical Name:
GSK3179106
CAS Number:
1627856-64-7
Molecular Formula:
C22H21F4N3O4
Molecular Weight:
467.4135
MDL Number:
MFCD30747847
SMILES:
CCOc1cc(=O)[nH]cc1c1ccc(c(c1)F)CC(=O)Nc1noc(c1)C(C(F)(F)F)(C)C
Properties
Computed Properties
 
Complexity:
812  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
3.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1Locationinpatent:Page/Pagecolumn123

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1Locationinpatent:Page/Pagecolumn33;39;40

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

114897-91-5   
2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide 

[1]Patent:WO2014/141187,2014,A1

[2]Patent:WO2016/38519,2016,A1

[3]ACSMedicinalChemistryLetters,2018,vol.9,p.623-628

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

114897-92-6   
2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide 

[1]Patent:WO2014/141187,2014,A1

[2]Patent:WO2016/38519,2016,A1

[3]ACSMedicinalChemistryLetters,2018,vol.9,p.623-628

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1627856-64-7
Tags:1627856-64-7 Molecular Formula|1627856-64-7 MDL|1627856-64-7 SMILES|1627856-64-7 GSK3179106
Catalog No.: AA01EO24
1627856-64-7,MFCD30747847
1627856-64-7 | GSK3179106
Pack Size: 1mg
Purity: 98%
in stock
$27.00 $19.00
Pack Size: 5mg
Purity: 98%
in stock
$66.00 $47.00
Pack Size: 10mg
Purity: 98%
in stock
$99.00 $69.00
Pack Size: 50mg
Purity: 98%
in stock
$281.00 $197.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01EO24
Chemical Name: GSK3179106
CAS Number: 1627856-64-7
Molecular Formula: C22H21F4N3O4
Molecular Weight: 467.4135
MDL Number: MFCD30747847
SMILES: CCOc1cc(=O)[nH]cc1c1ccc(c(c1)F)CC(=O)Nc1noc(c1)C(C(F)(F)F)(C)C
Properties
Complexity: 812  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 33  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 7  
XLogP3: 3.4  
Downstream Synthesis Route
1627857-70-8    1627856-64-7 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1Locationinpatent:Page/Pagecolumn123

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1Locationinpatent:Page/Pagecolumn33;39;40

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

114897-91-5   
2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide 

[1]Patent:WO2014/141187,2014,A1

[2]Patent:WO2016/38519,2016,A1

[3]ACSMedicinalChemistryLetters,2018,vol.9,p.623-628

76283-09-5    1627856-64-7 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

114897-92-6   
2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide 

[1]Patent:WO2014/141187,2014,A1

[2]Patent:WO2016/38519,2016,A1

[3]ACSMedicinalChemistryLetters,2018,vol.9,p.623-628

1188911-73-0    1627856-64-7 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/141187,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/38519,2016,A1

[3]SchenckEidam,Hilary;Russell,John;Raha,Kaushik;Demartino,Michael;Qin,Donghui;Guan,HuipingAmy;Zhang,Zhiliu;Zhen,Gong;Yu,Haiyu;Wu,Chengde;Pan,Yan;Joberty,Gerard;Zinn,Nico;Laquerre,Sylvie;Robinson,Sharon;White,Angela;Giddings,Amanda;Mohammadi,Ehsan;Greenwood-VanMeerveld,Beverly;Oliff,Allen;Kumar,Sanjay;Cheung,Mui[ACSMedicinalChemistryLetters,2018,vol.9,#7,p.623-628]

Building Blocks More >
1643368-58-4
1643368-58-4
BMS-986142
AA01EO5O
2084868-04-0
2084868-04-0
Capzimin
AA01EOB6 | MFCD31657375
2070014-98-9
2070014-98-9
IFN alpha-IFNAR-IN-1 hydrochloride
AA01EOH8
1599440-33-1
1599440-33-1
Dxd
AA01EOML | MFCD31657444
1307803-47-9
1307803-47-9
(1-butyl-5-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone
AA01EOTE | MFCD18382141
117342-78-6
117342-78-6
4-methyl-α-[(1R)-1-(methylamino)ethyl]-benzenemethanol,monohydrochloride
AA01EP21
2108631-19-0
2108631-19-0
N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-1,2-ethanediamine,trihydrochloride
AA01EPBZ
1630743-73-5
1630743-73-5
3-(2-fluorophenyl)-N7,N7-dimethyl-2,7-quinolinediamine
AA01EPIO | MFCD28580129
1133706-15-6
1133706-15-6
B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-(phenyl-2,3,4,5,6-d5)-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronicacid
AA01EPOF
1071654-84-6
1071654-84-6
N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-heptadecanamide
AA01EPUS
Submit
© 2017 AA BLOCKS, INC. All rights reserved.